Tesevatinib
Tesevatinib
Tesevatinib (pronounced te-se-va-ti-nib) is a type of pharmaceutical drug used in the treatment of various types of cancer. It is a tyrosine kinase inhibitor, which works by blocking certain proteins that can cause cells to grow and divide uncontrollably.
Etymology
The name "Tesevatinib" is derived from the combination of the words "tyrosine", "serine", and "valine", which are types of amino acids, and "nib", which is a common suffix for tyrosine kinase inhibitors.
Usage
Tesevatinib is used in the treatment of several types of cancer, including renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma. It is also being studied for use in other types of cancer.
Side Effects
Like all drugs, Tesevatinib can cause side effects. These may include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include liver damage, heart problems, and bleeding.
Related Terms
- Tyrosine kinase inhibitor
- Renal cell carcinoma
- Non-small cell lung cancer
- Hepatocellular carcinoma
- Amino acids
External links
- Medical encyclopedia article on Tesevatinib
- Wikipedia's article - Tesevatinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski